Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2021.750969 http://scihub22266oqcxt.onion/10.3389/fimmu.2021.750969 34858407!8631293!34858407     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2021 ; 12 (ä): 750969 Nephropedia Template TP {{tp|p=34858407|t=2021. SARS-CoV-2 Nsp5 Activates NF-kappaB Pathway by Upregulating SUMOylation of MAVS |pdf=|usr=}}{{34858407}} gab.com Text SARS-CoV-2 Nsp5 Activates NF-kappaB Pathway by Upregulating SUMOylation of MAVS JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34858407 #FOAvip The COVID-19 is an infectious disease caused by SARS-CoV-2 infection. A large number of clinical studies found high-level expression of pro-inflammatory cytokines in patients infected with SARS-CoV-2, which fuels the rapid development of the disease. However, the specific molecular mechanism is still unclear. In this study, we found that SARS-CoV-2 Nsp5 can induce the expression of cytokines IL-1beta, IL-6, TNF-alpha, and IL-2 in Calu-3 and THP1 cells. Further research found that Nsp5 enhances cytokine expression through activating the NF-kappaB signaling pathway. Subsequently, we investigated the upstream effectors of the NF-kappaB signal pathway on Nsp5 overexpression and discovered that Nsp5 increases the protein level of MAVS. Moreover, Nsp5 can promote the SUMOylation of MAVS to increase its stability and lead to increasing levels of MAVS protein, finally triggering activation of NF-kappaB signaling. The knockdown of MAVS and the inhibitor of SUMOylation treatment can attenuate Nsp5-mediated NF-kappaB activation and cytokine induction. We identified a novel role of SARS-CoV-2 Nsp5 to enhance cytokine production by activating the NF-kappaB signaling pathway. Twit Text FOAVip SARS-CoV-2 Nsp5 Activates NF-kappaB Pathway by Upregulating SUMOylation of MAVS ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34858407 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34858407 #FOAvip English Wikipedia <ref>{{Cite pmid|34858407}}</ref> SARS-CoV-2 Nsp5 Activates NF-kappaB Pathway by Upregulating SUMOylation of MAVS #MMPMID34858407 Li W; Qiao J; You Q; Zong S; Peng Q; Liu Y; Hu S; Liu W; Li S; Shu X; Sun B Front Immunol 2021[]; 12 (ä): 750969 PMID34858407show ga The COVID-19 is an infectious disease caused by SARS-CoV-2 infection. A large number of clinical studies found high-level expression of pro-inflammatory cytokines in patients infected with SARS-CoV-2, which fuels the rapid development of the disease. However, the specific molecular mechanism is still unclear. In this study, we found that SARS-CoV-2 Nsp5 can induce the expression of cytokines IL-1beta, IL-6, TNF-alpha, and IL-2 in Calu-3 and THP1 cells. Further research found that Nsp5 enhances cytokine expression through activating the NF-kappaB signaling pathway. Subsequently, we investigated the upstream effectors of the NF-kappaB signal pathway on Nsp5 overexpression and discovered that Nsp5 increases the protein level of MAVS. Moreover, Nsp5 can promote the SUMOylation of MAVS to increase its stability and lead to increasing levels of MAVS protein, finally triggering activation of NF-kappaB signaling. The knockdown of MAVS and the inhibitor of SUMOylation treatment can attenuate Nsp5-mediated NF-kappaB activation and cytokine induction. We identified a novel role of SARS-CoV-2 Nsp5 to enhance cytokine production by activating the NF-kappaB signaling pathway. |Adaptor Proteins, Signal Transducing/genetics/*metabolism[MESH] |Animals[MESH] |COVID-19/immunology[MESH] |Cell Line[MESH] |Chlorocebus aethiops[MESH] |Coronavirus 3C Proteases/*immunology[MESH] |Cytokines/*biosynthesis[MESH] |Enzyme Activation/drug effects[MESH] |HEK293 Cells[MESH] |Humans[MESH] |Immunity, Innate/immunology[MESH] |Interleukin-1beta/biosynthesis[MESH] |Interleukin-2/biosynthesis[MESH] |Interleukin-6/biosynthesis[MESH] |NF-kappa B/*metabolism[MESH] |SARS-CoV-2/*immunology[MESH] |Signal Transduction/physiology[MESH] |Sumoylation/drug effects/*physiology[MESH] |THP-1 Cells[MESH] |Tumor Necrosis Factor-alpha/biosynthesis[MESH]SARS-CoV-2 Nsp5 Activates NF-kappaB Pathway by Upregulating SUMOylatio(epmc).pdf DeepDyve Pubget Overpricing